1
|
Chai CA, Somani B, Castellani D, Fong KY, Sarica K, Emiliani E, Ong WLK, Ragoori D, Gökce MI, Gadzhiev N, Tanidir Y, Lakmichi MA, Inoue T, Pirola GM, Teoh JYC, Hamri SB, Tursunkulov AN, Ganpule A, Chew BH, Traxer O, Gauhar V. Comparing Same-Sitting Bilateral vs Unilateral Retrograde Intrarenal Surgery in the Elderly. Urology 2024; 186:117-122. [PMID: 38417468 DOI: 10.1016/j.urology.2024.02.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 02/14/2024] [Accepted: 02/21/2024] [Indexed: 03/01/2024]
Abstract
OBJECTIVE To compare same-sitting bilateral vs unilateral retrograde intrarenal surgery (RIRS) in elderly patients, focusing on postoperative complications and stone-free rates (SFR). METHODS Data from 2 multicenter databases, FLEXible ureteroscopy Outcomes Registry (FLEXOR) (unilateral RIRS) and same sitting bilateral-retrograde intrarenal surgery (SSB-RIRS) (bilateral RIRS), were analyzed, considering only patients aged 70+ with preoperative computed tomography. Patients were categorized into Group 1 (bilateral RIRS) and Group 2 (unilateral RIRS). Follow-up included imaging assessments and secondary treatments as needed. RESULTS Group 1 included 146 patients, while group 2 had 495. Group 1's patients were slightly older and had a higher prevalence of recurrent stone formation. Group 2 often underwent RIRS for incidental stones. Group 1 had larger and more pelvic stones. Laser lithotripsy and total operation times were significantly longer in Group 1. Group 2 had significantly higher overall stone-free rates, although there were no significant differences in ancillary procedures for residual fragments. Group 1 experienced more pelvicalyceal injuries needing stenting, postoperative fever, and post-op hematuria not requiring transfusion. CONCLUSION In conclusion, bilateral RIRS can be carefully considered in elderly patients. Preoperative counseling is essential for both primary and repeat RIRS procedures, and further research is needed to optimize instrument and laser strategies for better outcomes in elderly RIRS patients.
Collapse
Affiliation(s)
- Chu Ann Chai
- University Malaya, Department of Surgery Urology Unit, Kuala Lumpur, Malaysia.
| | - Bhaskar Somani
- University Hospital Southampton NHS Foundation Trust, Department of Urology, Southampton, United Kingdom
| | - Daniele Castellani
- Azienda ospedaliero universitaria Ospedali riuniti di Ancona Universita Politecnica delle Marche, Department of Urology, Ancona, Italy
| | - Khi Yung Fong
- Yong Loo Lin School of Medicine National University of Singapore, Faculty of Medicine, Singapore, Singapore
| | - Kemal Sarica
- Biruni University Medical School, Department of Urology, Istanbul, Turkey
| | - Estaban Emiliani
- Fundacion Puigvert Autónomos University of Barcelona, Department of Urology, Barcelona, Spain
| | | | - Deepak Ragoori
- Asian Institute Of Nephrology and Urology, Department of Urology, Hyderabad, India
| | - Mehmet Ilker Gökce
- Ankara University School of Medicine, Department of Urology, Ankara, Turkey
| | - Nariman Gadzhiev
- Saint Petersburg State University Hospital Russia, Department of Urology, St Petersburg, Russia
| | - Yiloren Tanidir
- Marmara University School of Medicine, Department of Urology, Istanbul, Turkey
| | - Mohamed Amine Lakmichi
- University Hospital Mohammed the VIth of Marrakesh, Department of Urology, Marrakesh, Morocco
| | - Takaaki Inoue
- Hara Genitourinary Private Hospital and Kobe University, Department of Urology, Kobe, Japan
| | | | | | - Saeed Bin Hamri
- King Abdullah International Medical Research Center, Department of Surgery, Riyadh, Saudi Arabia
| | | | - Arvind Ganpule
- Muljibhai Patel Urological Hospital, Department of Urology, Nadiad, Gujarat, India
| | - Ben Hall Chew
- University of British Columbia, Department of Urology, Vancouver, Canada
| | - Olivier Traxer
- Sorbonne University GRC Urolithiasis Tenon Hospital, Department of Urology, Paris, France
| | - Vineet Gauhar
- Ng Teng Fong General Hospital, Department of Urology, Singapore, Singapore
| |
Collapse
|
2
|
Castellani D, Traxer O, Ragoori D, Galosi AB, De Stefano V, Gadzhiev N, Tanidir Y, Inoue T, Emiliani E, Hamri SB, Lakmichi MA, Vaddi CM, Heng CT, Soebhali B, More S, Sridharan V, Gökce MI, Tursunkulov AN, Ganpule A, Pirola GM, Naselli A, Aydin C, Ramón de Fata Chillón F, Mendoza CS, Candela L, Chew BH, Somani BK, Gauhar V. Improving Outcomes of Same-sitting Bilateral Flexible Ureteroscopy for Renal Stones in Real-world Practice-Lessons Learnt from Global Multicenter Experience of 1250 Patients. EUR UROL SUPPL 2023; 52:51-59. [PMID: 37284041 PMCID: PMC10240508 DOI: 10.1016/j.euros.2023.03.018] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/29/2023] [Indexed: 06/08/2023] Open
Abstract
Background Bilateral kidney stones are commonly treated in staged procedures. Objective To evaluate outcomes after same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) for renal stones. Design setting and participants Data from adults who underwent bilateral RIRS in 21 centers were retrospectively reviewed (from January 2015 to June 2022). The inclusion criteria were unilateral/bilateral symptomatic bilateral stone(s) of any size/location in both kidneys and bilateral stones on follow-up with symptom/stone progression. Stone-free rate (SFR) was defined as absence of any fragment >3 mm at 3 mo. Outcome measurements and statistical analysis Continuous variables are presented as medians and 25-75th percentiles. A multivariable logistic regression analysis was performed to evaluate independent predictors of sepsis and bilateral SFR. Results and limitations A total of 1250 patients were included. The median age was 48.0 (36-61) yr. Of the patients, 58.2% were prestented. The median stone diameter was 10 mm on both sides. Multiple stones were present in 45.3% and 47.9% of the left and right kidneys, respectively. Surgery was stopped in 6.8% of cases. The median surgical time was 75.0 (55-90) min. Complications were transient fever (10.7%), fever/infection needing prolonged stay (5.5%), sepsis (2%), and blood transfusion (1.3%). Bilateral and unilateral SFRs were 73.0% and 17.4%, respectively. Female (odds ratio [OR] 2.97, 95% confidence interval [CI] 1.18-7.49, p = 0.02), no antibiotic prophylaxis (OR 5.99, 95% CI 2.28-15.73, p < 0.001), kidney anomalies (OR 5.91, 95% CI 1.96-17.94, p < 0.001), surgical time ≥100 min (OR 2.86, 95% CI 1.12-7.31, p = 0.03) were factors associated with sepsis. Female (OR 1.88, 95% CI 1.35-2.62, p < 0.001), bilateral prestenting (OR 2.16, 95% CI 1.16-7.66, p = 0.04), and the use of high-power holmium:YAG laser (OR 1.63, 95% CI 1.14-2.34, p < 0.01) and thulium fiber laser (OR 2.50, 95% CI 1.32-4.74, p < 0.01) were predictors of bilateral SFR. Limitations were retrospective study and no cost analysis. Conclusions SSB-RIRS is an effective treatment with an acceptable complication rate in selected patients with kidney stones. Patient summary In this large multicenter study, we looked at outcomes after same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) for renal stones in a large cohort. We found that SSB-RIRS was associated with acceptable morbidity and good stone clearance after a single session.
Collapse
Affiliation(s)
- Daniele Castellani
- Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy
| | - Olivier Traxer
- Department of Urology AP-HP, Sorbonne University, Tenon Hospital, Paris, France
| | - Deepak Ragoori
- Department of Urology, Asian Institute of Nephrology & Urology, Irram Manzil Colony, Hyderabad, Telangana, India
| | - Andrea Benedetto Galosi
- Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy
| | - Virgilio De Stefano
- Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy
| | - Nariman Gadzhiev
- Department of Urology, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia
| | - Yiloren Tanidir
- Department of Urology, School of Medicine, Marmara University, İstanbul, Turkey
| | - Takaaki Inoue
- Department of Urology, Hara Genitourinary Private Hospital, Kobe University, Kobe, Japan
| | - Esteban Emiliani
- Department of Urology, Fundacion Puigvert, Autónomos University of Barcelona, Barcelona, Spain
| | - Saeed Bin Hamri
- Division of Urology, Department of Surgery, Ministry of the National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
| | - Mohamed Amine Lakmichi
- Department of Urology, University Hospital Mohammed the VIth of Marrakesh, Marrakesh, Morocco
| | | | - Chin Tiong Heng
- Department of Urology, Ng Teng Fong General Hospital, Singapore, Singapore
| | - Boyke Soebhali
- Department of Urology, Abdul Wahab Sjahranie Hospital, Medical Faculty Mulawarman University, Samarinda, Indonesia
| | - Sumit More
- Department of Urology, Sarvodaya Hospital and Research Centre, Faridabad, India
| | - Vikram Sridharan
- Department of Urology, Sree Paduka Speciality Hospital, Thillai Nagar, India
| | - Mehmet Ilker Gökce
- Department of Urology, Ankara University, School of Medicine, Ankara, Turkey
| | | | - Arvind Ganpule
- Department of Urology, Muļjibhai Patel Urological Hospital, Nadiad, Gujarat, India
| | - Giacomo Maria Pirola
- Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy
| | - Angelo Naselli
- Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy
| | - Cemil Aydin
- Department of Urology, Hitit University, School of Medicine, Çorum, Turkey
| | | | - Catalina Solano Mendoza
- Department of Urology AP-HP, Sorbonne University, Tenon Hospital, Paris, France
- Department of Endourology, Uroclin S.A.S, Medellín, Colombia
| | - Luigi Candela
- Department of Urology AP-HP, Sorbonne University, Tenon Hospital, Paris, France
- Division of Experimental Oncology/Unit of Urology, URI-Urological Research Institute IRCCS Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
| | - Ben Hall Chew
- Department of Urology, University of British Columbia, Vancouver, Canada
| | - Bhaskar Kumar Somani
- Department of Urology, University Hospitals Southampton, NHS Trust, Southampton, UK
| | - Vineet Gauhar
- Department of Urology, Ng Teng Fong General Hospital, Singapore, Singapore
| |
Collapse
|
3
|
Sorensen MD, Harper JD, Borofsky MS, Hameed TA, Smoot KJ, Burke BH, Levchak BJ, Williams JC, Bailey MR, Liu Z, Lingeman JE. Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse. N Engl J Med 2022; 387:506-513. [PMID: 35947709 PMCID: PMC9741871 DOI: 10.1056/nejmoa2204253] [Citation(s) in RCA: 33] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
BACKGROUND The benefits of removing small (≤6 mm), asymptomatic kidney stones endoscopically is unknown. Current guidelines leave such decisions to the urologist and the patient. A prospective study involving older, nonendoscopic technology and some retrospective studies favor observation. However, published data indicate that about half of small renal stones left in place at the time that larger stones were removed caused other symptomatic events within 5 years after surgery. METHODS We conducted a multicenter, randomized, controlled trial in which, during the endoscopic removal of ureteral or contralateral kidney stones, remaining small, asymptomatic stones were removed in 38 patients (treatment group) and were not removed in 35 patients (control group). The primary outcome was relapse as measured by future emergency department visits, surgeries, or growth of secondary stones. RESULTS After a mean follow-up of 4.2 years, the treatment group had a longer time to relapse than the control group (P<0.001 by log-rank test). The restricted mean (±SE) time to relapse was 75% longer in the treatment group than in the control group (1631.6±72.8 days vs. 934.2±121.8 days). The risk of relapse was 82% lower in the treatment group than the control group (hazard ratio, 0.18; 95% confidence interval, 0.07 to 0.44), with 16% of patients in the treatment group having a relapse as compared with 63% of those in the control group. Treatment added a median of 25.6 minutes (interquartile range, 18.5 to 35.2) to the surgery time. Five patients in the treatment group and four in the control group had emergency department visits within 2 weeks after surgery. Eight patients in the treatment group and 10 in the control group reported passing kidney stones. CONCLUSIONS The removal of small, asymptomatic kidney stones during surgery to remove ureteral or contralateral kidney stones resulted in a lower incidence of relapse than nonremoval and in a similar number of emergency department visits related to the surgery. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Veterans Affairs Puget Sound Health Care System; ClinicalTrials.gov number, NCT02210650.).
Collapse
Affiliation(s)
- Mathew D Sorensen
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Jonathan D Harper
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Michael S Borofsky
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Tariq A Hameed
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Kimberly J Smoot
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Barbara H Burke
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Branda J Levchak
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - James C Williams
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Michael R Bailey
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - Ziyue Liu
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| | - James E Lingeman
- From the Department of Urology, University of Washington School of Medicine (M.D.S., J.D.H.), the Division of Urology (M.D.S., M.R.B.) and the Seattle Institute for Biomedical and Clinical Research (B.J.L.), Veterans Affairs Puget Sound Health Care System, and the Institute of Translational Health Sciences (B.H.B.) and the Center for Industrial and Medical Ultrasound, Applied Physics Laboratory (M.R.B.), University of Washington - all in Seattle; the Department of Urology, University of Minnesota, Minneapolis (M.S.B.); and the Departments of Radiology and Imaging Sciences (T.A.H.), Urology (K.J.S., J.E.L.), Cell Biology and Physiology (J.C.W.), and Biostatistics and Health Data Science (Z.L.), Indiana University School of Medicine, Indianapolis
| |
Collapse
|
4
|
Wu T, Liu Z, Ma S, Xue W, Jiang X, Ma J. Should we support prophylactic intervention for asymptomatic kidney stones? A retrospective cohort study with long-term follow-up. Urolithiasis 2022; 50:431-437. [PMID: 35622129 PMCID: PMC9137265 DOI: 10.1007/s00240-022-01331-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2022] [Accepted: 05/08/2022] [Indexed: 12/23/2022]
Abstract
The purpose of this study was to evaluate the long-term outcomes of patients undergoing prophylactic intervention or active surveillance for asymptomatic kidney stones and identify factors influencing the outcomes. In this retrospective cohort study, we reviewed the medical records of patients with asymptomatic kidney stones in two institutes between November 2014 and November 2019. Standardized questions were asked via phone calls to supplement the outcomes. Pain, hydronephrosis, stone growth, serious infection, gross hematuria, and spontaneous passage were defined as stone-related events. Future intervention was also recorded to evaluate management. A total of 101 patients with 120 kidney units were enrolled in this study. The median follow-up time was 63 months. The patients were classified into the control group (79 cases) or exposure group (41 cases) according to whether they underwent prophylactic intervention before any stone-related events. Generally, the rates of stone-related events and future intervention were significantly different between the two groups (57.0 vs. 12.2%, p < 0.001; and 31.6 vs. 4.9%, p = 0.002, respectively). After applying stabilized inverse probability of treatment weighted, Cox regression suggested that patients who underwent prophylactic intervention were less likely to experience stone-related events and future intervention (HR = 0.175, and HR = 0.028, respectively). In conclusion, patients who underwent prophylactic intervention had a lower risk of stone-related events and future intervention, although they had some slight complications.
Collapse
Affiliation(s)
- Tao Wu
- Department of Urology, Tangdu Hospital, Air Force Medical University, 1 Xinsi Rd, Xi’an, 710038 China
| | - Zhiwei Liu
- Department of Urology, Tangdu Hospital, Air Force Medical University, 1 Xinsi Rd, Xi’an, 710038 China
| | - Shanjin Ma
- Department of Urology, Tangdu Hospital, Air Force Medical University, 1 Xinsi Rd, Xi’an, 710038 China
| | - Wei Xue
- Department of Urology, Tangdu Hospital, Air Force Medical University, 1 Xinsi Rd, Xi’an, 710038 China
| | - Xiaoye Jiang
- Department of Urology, Tangdu Hospital, Air Force Medical University, 1 Xinsi Rd, Xi’an, 710038 China
| | - Jianjun Ma
- Department of Urology, Tangdu Hospital, Air Force Medical University, 1 Xinsi Rd, Xi'an, 710038, China.
| |
Collapse
|